Neonatal Cytomegalovirus Infection: Advocacy, Legislation, and Changing Practice

Ashley Stark1, Chelsea M Crooks2, Sallie R Permar3

  • 1Department of Pediatrics, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA.

Clinics in Perinatology
|February 1, 2025
PubMed

Insights

Congenital Cytomegalovirus (cCMV) is a common infection impacting infant development. Early screening and intervention are crucial for improving outcomes and reducing long-term health issues.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Cytomegalovirus (CMV) is the most frequent intrauterine infection.
  • Congenital CMV (cCMV) can lead to significant long-term sequelae, including sensorineural hearing loss and neurodevelopmental impairment, in up to 25% of affected infants.
  • Despite the availability of antiviral therapies and early intervention services, cCMV imposes a considerable economic burden.

Purpose of the Study:

  • To evaluate the cost-effectiveness of different screening strategies for congenital CMV.
  • To highlight the limitations of targeted screening in identifying at-risk infants.
  • To discuss the varied state-based approaches to cCMV screening in the United States.

Main Methods:

  • Review of existing studies on the cost-effectiveness of CMV screening.
  • Analysis of the efficacy of targeted versus universal screening approaches.
  • Examination of current state-based screening policies in the US.

Main Results:

  • Both targeted and universal screening for cCMV have demonstrated cost-effectiveness.
  • Targeted screening methods often fail to identify a significant number of infants who are at risk for developing cCMV-related sequelae.
  • Current screening policies for cCMV in the United States are inconsistent, ranging from universal screening to education-only approaches.

Conclusions:

  • Universal screening for cCMV is more effective in identifying at-risk infants compared to targeted screening.
  • Standardizing cCMV screening protocols across states is essential for early detection and intervention.
  • Implementing effective screening strategies can mitigate the long-term health and economic consequences of congenital CMV infection.